Clinical Trial Update: Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A phase 1 study evaluating the safety of combining Imatinib Mesylate with chemotherapy in patients with extensive-stage small cell lung cancer; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED